Expert NetworkExpert InterviewINCY

Slingshot members are talking to an expert! The topic is:

Discussing the Phase 1/2 study of the ALK2 inhibitor zilurgisertib as a monotherapy or with ruxolitinib in patients with anemia due to myelofibrosis

Executed on:Aug 22, 2023 12:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: MD Anderson
  • Associate Professor of Medicine, Department of Leukemia at MD Anderson.
  • Manages 40 patients with systemic mastocytosis.
  • Research focus is on myeloproliferative neoplasms (MPNs). Heavily involved in clinical trial design for patients with MPN, and also in other areas of MPN research; leads number of important therapeutic clinical trials in myelofibrosis at MDACC, as well as in other MPNs such as essential thrombocythemia and systemic mastocytosis (PI on APEX, SUMMIT, HARBOR).

Interview Goal

Discuss the phase 1/2 poster presented by a paper author during ASCO

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.